Minutia
Oakland · Founded 2021
About Minutia
Developing stem cell derived transplants that can communicate transplant status in vivo and are resistant to common transplant challenges, initially focused on enabling a functional cure for Type 1 Diabetes
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2024)
- Website: http://minutia.co
Industries & Categories
Biotechnology, Diabetes, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/minutia-139321 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.